| mRNA |
COL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
WZ4002 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.0092 |
0.9 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.0085 |
0.9 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |
| mRNA |
GSK1059615 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |